Objective: To explore personality characteristics and personality types of drug users. Methods: 192 cases of drug users were tested using CPI and the cluster analysis was based on the data of 20 sub-scales. Results: F...Objective: To explore personality characteristics and personality types of drug users. Methods: 192 cases of drug users were tested using CPI and the cluster analysis was based on the data of 20 sub-scales. Results: First, in Sociability and Flexibility two sub-scales the drug user present better than the normal group, but in other sub-scales were worse or much worse such as Responsibility, Socialization, Sense of Wellbeing, Achievement Via Conformance and Achievement Via Independence sub-scales. Second, 192 cases of drug users were divided into four groups by hierarchical cluster analysis, they were Sociality, Idleness, Independence and Conformance. Conclusion: The drug users had some special personality characteristics and they were divided into four typical personality types.展开更多
Today, with the introduction of interferon-free direct-acting antivirals and outstanding progresses in the prevention, diagnosis and treatment of hepatitis C virus(HCV) infection, the elimination of HCV infection seem...Today, with the introduction of interferon-free direct-acting antivirals and outstanding progresses in the prevention, diagnosis and treatment of hepatitis C virus(HCV) infection, the elimination of HCV infection seems more achievable. A further challenge is continued transmission of HCV infection in high-risk population specially injecting drug users(IDUs) as the major reservoir of HCV infection. Considering the fact that most of these infections remain undiagnosed, unidentified HCVinfected IDUs are potential sources for the rapid spread of HCV in the community. The continuous increase in the number of IDUs along with the rising prevalence of HCV infection among young IDUs is harbinger of a forthcoming public health dilemma, presenting a serious challenge to control transmission of HCV infection. Even the changes in HCV genotype distribution attributed to injecting drug use confirm this issue. These circumstances create a strong demand for timely diagnosis and proper treatment of HCV-infected patients through risk-based screening to mitigate the risk of HCV transmission in the IDUs community and, consequently, in the society. Meanwhile, raising general awareness of HCV infection, diagnosis and treatment through public education should be the core activity of any harm reduction intervention, as the root cause of failure in control of HCV infection has been lack of awareness among young drug takers. In addition, effective prevention, comprehensive screening programs with a specific focus on high-risk population, accessibility to the new anti-HCV treatment regimens and public education should be considered as the top priorities of any health policy decision to eliminate HCV infection.展开更多
文摘Objective: To explore personality characteristics and personality types of drug users. Methods: 192 cases of drug users were tested using CPI and the cluster analysis was based on the data of 20 sub-scales. Results: First, in Sociability and Flexibility two sub-scales the drug user present better than the normal group, but in other sub-scales were worse or much worse such as Responsibility, Socialization, Sense of Wellbeing, Achievement Via Conformance and Achievement Via Independence sub-scales. Second, 192 cases of drug users were divided into four groups by hierarchical cluster analysis, they were Sociality, Idleness, Independence and Conformance. Conclusion: The drug users had some special personality characteristics and they were divided into four typical personality types.
文摘Today, with the introduction of interferon-free direct-acting antivirals and outstanding progresses in the prevention, diagnosis and treatment of hepatitis C virus(HCV) infection, the elimination of HCV infection seems more achievable. A further challenge is continued transmission of HCV infection in high-risk population specially injecting drug users(IDUs) as the major reservoir of HCV infection. Considering the fact that most of these infections remain undiagnosed, unidentified HCVinfected IDUs are potential sources for the rapid spread of HCV in the community. The continuous increase in the number of IDUs along with the rising prevalence of HCV infection among young IDUs is harbinger of a forthcoming public health dilemma, presenting a serious challenge to control transmission of HCV infection. Even the changes in HCV genotype distribution attributed to injecting drug use confirm this issue. These circumstances create a strong demand for timely diagnosis and proper treatment of HCV-infected patients through risk-based screening to mitigate the risk of HCV transmission in the IDUs community and, consequently, in the society. Meanwhile, raising general awareness of HCV infection, diagnosis and treatment through public education should be the core activity of any harm reduction intervention, as the root cause of failure in control of HCV infection has been lack of awareness among young drug takers. In addition, effective prevention, comprehensive screening programs with a specific focus on high-risk population, accessibility to the new anti-HCV treatment regimens and public education should be considered as the top priorities of any health policy decision to eliminate HCV infection.
